Infectious Disease Therapeutics Market: By Drug class, By disease indication, By Distribution channel, and Geography

Infectious Disease Therapeutics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug class (Anti-Bacterial, Anti-Viral, Anti-Parasite, Anti-Fungal, Others), By disease indication (HIV/AIDS, Influenza, Hepatitis, Malaria, TB, Others), By Distribution channel (Hospital Pharmacy, Retail Pharmacy, Others), and Region

Infectious disease therapeutics market size valued US$ 138.98 billion in 2023 and expected to reach US$ 175.32 billion by 2030, at a CAGR of 7.8% during the forecast period 2024-2030. Infectious diseases are caused by organisms, such as bacteria, virus, fungi or parasites. Many organisms live in our body but few of them cause diseases. These infectious diseases are transmitted from one individual to other either by direct or indirect contact. The drugs used for infectious diseases are antibiotics, antiviral, and antiparasitic, among others. Infectious disease therapeutics acts directly on organisms or helps the body system to fight infections. Infectious diseases include HIV, malaria, tuberculosis, hepatitis, and influenza, among others. Market players focus on mergers, acquisitions and collaborations to increase revenue share in the market.

For instance, in August 2016, Pfizer acquired AstraZeneca's late-stage small molecule anti-infectives business for development and commercialization outside the U.S. In addition, market players investing on research and development to introduce new drugs and to strengthen their position in the market. Some of the pipeline anti-infectives include avycaz (ceftazidime and avibactam), bictegravir (Anti HIV), cabotegravir (Anti HIV). Patent expiry of blockbuster anti-infectives such as Tamiflu, cubicin and ambisome are expected to negatively effect the infectious disease therapeutics industry.

Infectious Disease Therapeutics Market Key Developments:

In July 2017, Gilead's oral tablet was approved by U.S. FDA for treatment of adults with chronic hepatitis C virus
In March 2015, U.S. Food and Drug Administration approved cresemba (isavuconazonium sulfate), a novel antifungal drug for treat adults with invasive aspergillosis and invasive mucormycosis, rare but serious infections
In December 2014, Sanofi Pasteur announces FDA approval of fluzone intradermal quadrivalent (Influenza Vaccine) for adults.

Download Sample

Global Infectious Disease Therapeutics Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

7.8%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Infectious Disease Therapeutics Market Dynamics

Infectious disease therapeutics market is driven by the growing prevalence rates of infectious diseases, increased healthcare expenditure and increased funding of governments on prevention and management of infectious diseases. In addition, increased geriatric population and use of direct acting antiviral drugs are fuelling the growth of infectious diseases therapeutics market. However, patent expiry of many infectious disease drugs and increase number of generic alternatives hindering the market revenue of market.

North America Got Significant Share

Infectious Disease Therapeutics Market Regional Analysis

Geographically market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the infectious disease therapeutics market owing to high prevalence rates of infectious diseases and rise in ageing population. According to scientific data from Princeton University 2015, rising trend in consumption of anti-infectives has increased in BRICS nation. In the last few years, there was an increase in use of antibiotics in Asian countries like India and China and some parts of Africa. Factors such as rapidly developing healthcare infrastructure on the grounds of emerging medical tourism industry along with government initiative to boost biotechnology sector of the respective country are fuelling the growth of the market in Asia Pacific region.

Latin America

Europe

Asia Pacific

Middle East

North America

Global Infectious Disease Therapeutics Market Segmentation Analysis

Report Benchmarks	Details
Report Study Period	2025-2031
Market Size in 2023	US$ 138.98 billion
Market Size in 2030	US$ 175.32 billion
Market CAGR	7.8%
By Drug Class	Anti-Bacterial Anti-Viral Anti-Parasite Anti-Fungal Others
By Disease Indication	HIV/AIDS Influenza Hepatitis Malaria TB Others
By Distribution Channel	Hospital Pharmacy Retail Pharmacy Others

Key Features of the Report

The infectious disease therapeutics market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments, and start-up details that are actively working in the market
The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The infectious disease therapeutics market was expected to grow at a significant compound annual growth rate (CAGR) of 7.8% from 2023 to 2029. Additionally, it mentions that the market value was US$ 128.4 billion in 2022.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

Executive summary
Global Infectious Disease Therapeutics Market Introduction
- Global Infectious Disease Therapeutics Market - Taxonomy
- Global Infectious Disease Therapeutics Market - Definitions
  - Drug Class
  - Disease Indication

Global Infectious Disease Therapeutics Market Dynamics
- Drivers
- Restraints
- Opportunities/Unmet Needs of the Market
- Trends
- Global Infectious Disease Therapeutics Market Dynamics - Factors Impact Analysis
- Global Infectious Disease Therapeutics Market - Regulations
  - US
  - Europe
  - Japan

Global Infectious Disease Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%)
- Market Oppurtunity Analysis
Global Infectious Disease Therapeutics Market, By Drug Class, 2018 - 2022 and Forecast, 2023 - 2029
- Anti -Bacterial
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Anti -Viral
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Anti -Parasite
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Anti -Fungal
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Others
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis

Global Infectious Disease Therapeutics Market Forecast, By Disease Indication, 2018 - 2022 and Forecast, 2023 - 2029
- HIV/AIDS
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Influenza
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Hepatitis
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Malaria
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Tuberculosis (TB)
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Others
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis

Global Infectious Disease Therapeutics Market Forecast, By Distribution Channel, 2018 - 2022 and Forecast, 2023 - 2029
- Hospital Pharmacies
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Retail Pharmacies
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Online Pharmacies
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis

Global Infectious Disease Therapeutics Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029
- North America
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Europe
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Asia -Pacific
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Latin America
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Middle East and Africa
  - Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
  - Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
  - Market Opportunity Analysis
- Global Infectious Disease Therapeutics Market - Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Region, 2023 - 2029
North America Infectious Disease Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
- Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
  - Anti -Bacterial
  - Anti -Viral
  - Anti -Parasite
  - Anti -Fungal
  - Others
- Disease Indication Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
  - HIV/AIDS
  - Influenza
  - Hepatitis
  - Malaria
  - TB
  - Others
- Distribution Channel Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y -o -Y Growth (%) and Market Share (%)
  - S.
  - Canada
- North America Infectious Disease Therapeutics Market - Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Country, 2023 - 2029
- North America Infectious Disease Therapeutics Market Dynamics - Trends
Europe Infectious Disease Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
- Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
  - Anti -Bacterial
  - Anti -Viral
  - Anti -Parasite
  - Anti -Fungal
  - Others
- Disease Indication Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
  - HIV/AIDS
  - Influenza
  - Hepatitis
  - Malaria
  - TB
  - Others
- Distribution Channel Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
  - Germany
  - UK
  - France
  - Spain
  - Italy
  - Russia
  - Poland
  - Rest of Europe
- Europe Infectious Disease Therapeutics Market - Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Country, 2023 - 2029
- Europe Infectious Disease Therapeutics Market Dynamics - Trends
Asia -Pacific Infectious Disease Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
- Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
  - Anti -Bacterial
  - Anti -Viral
  - Anti -Parasite
  - Anti -Fungal
  - Others
- Disease Indication Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
  - HIV/AIDS
  - Influenza
  - Hepatitis
  - Malaria
  - TB
  - Others
- Distribution Channel Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn),
Y -o -Y Growth (%), and Market Share (%)
- Japan
- China
- India
- ASEAN
- Australia & New Zealand
- Rest of Asia -Pacific

Asia -Pacific Infectious Disease Therapeutics Market - Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Country, 2023 - 2029
Asia -Pacific Infectious Disease Therapeutics Market Dynamics - Trends

Latin America Infectious Disease Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
- Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
  - Anti -Bacterial
  - Anti -Viral
  - Anti -Parasite
  - Anti -Fungal
  - Others
- Disease Indication Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
  - HIV/AIDS
  - Influenza
  - Hepatitis
  - Malaria
  - TB
  - Others
- Distribution Channel Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
  - Brazil
  - Mexico
  - Argentina
  - Venezuela
  - Rest of Latin America
- Latin America Infectious Disease Therapeutics Market - Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Country, 2023 - 2029
- Latin America Infectious Disease Therapeutics Market Dynamics - Trends
Middle East & Africa Infectious Disease Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
- Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
  - Anti -Bacterial
  - Anti -Viral
  - Anti -Parasite
  - Anti -Fungal
  - Others
- Disease Indication Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
  - HIV/AIDS
  - Influenza
  - Hepatitis
  - Malaria
  - TB
  - Others
- Distribution Channel Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
  - Gulf Cooperation Council (GCC) Countries
  - Israel
  - South Africa
  - Rest of MEA
- MEA Infectious Disease Therapeutics Market - Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Country, 2023 - 2029
- MEA Infectious Disease Therapeutics Market Dynamics - Trends
Competition Landscape
- Strategic Dashboard of Top Market Players
- Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  - GlaxoSmithKline Plc (U.K.)
  - Johnson & Johnson Services, Inc. (U.S.)
  - Merck & Co, Inc. (U.S.)
  - Pfizer Inc. (U.S.)
  - Novartis AG. (Switzerland)
  - AbbVie Inc. (U.S.)
  - Astellas Pharma Inc. (Japan)
  - AstraZeneca (U.K.)
  - Auritec Pharmaceuticals Inc. (U.S.)
  - Bayer AG (Germany)
  - Chimerix Inc. (U.S.)
Research Methodology
Key Assumptions and Acronyms

Key Market Players

GlaxoSmithKline Plc (U.K.)
Johnson & Johnson Services, Inc. (U.S.)
Merck & Co, Inc. (U.S.)
Pfizer Inc. (U.S.)
Novartis AG. (Switzerland)
AbbVie Inc. (U.S.)
Astellas Pharma Inc. (Japan)
AstraZeneca (U.K.)
Auritec Pharmaceuticals Inc. (U.S.)
Bayer AG (Germany)
Modified Polymer Components, Inc. (Bristol-Myers Squibb) (U.S.)
Chimerix Inc. (U.S.)
Eli Lilly and Company (U.S.)
Isis Pharmaceuticals (U.S.)
Mitsubishi Chemical Holdings Corporation (Mitsubishi Tanabe Pharma) (Japan)
Sanofi S.A. (France)
Gilead Sciences (U.S.)

Related Industry Reports

Bacterial Vaccines Market

Invasive Fungal Infection Market

Global Anti Fungal Drugs Market

Hiv Diagnostics Market